Total Payments
$458,108
2024 Payments
$36,903
Companies
10
Transactions
429
Payment Breakdown by Category
Other$157,272 (34.3%)
Consulting$152,883 (33.4%)
Research$84,585 (18.5%)
Travel$49,464 (10.8%)
Food & Beverage$13,739 (3.0%)
Education$166.83 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $152,883 | 37 | 33.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,225 | 30 | 21.0% |
| Unspecified | $84,585 | 29 | 18.5% |
| Grant | $52,347 | 3 | 11.4% |
| Travel and Lodging | $49,464 | 78 | 10.8% |
| Food and Beverage | $13,739 | 245 | 3.0% |
| Honoraria | $8,700 | 1 | 1.9% |
| Education | $166.83 | 6 | 0.0% |
Payments by Type
General
$373,524
400 transactions
Research
$84,585
29 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $183,918 | 142 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $183,440 | 102 | $0 (2024) |
| ABBVIE INC. | $38,714 | 32 | $0 (2024) |
| Allergan, Inc. | $29,408 | 100 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $17,584 | 29 | $0 (2019) |
| Merz Pharmaceuticals GmbH | $4,708 | 19 | $0 (2017) |
| REVANCE THERAPEUTICS, INC. | $157.08 | 2 | $0 (2024) |
| Stryker Corporation | $84.03 | 1 | $0 (2019) |
| Galderma Research & Development, LLC | $61.31 | 1 | $0 (2023) |
| Sensus Healthcare, Inc. | $34.04 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,903 | 23 | Galderma Laboratories, L.P. ($22,163) |
| 2023 | $16,059 | 27 | ABBVIE INC. ($13,898) |
| 2022 | $44,856 | 36 | ABBVIE INC. ($24,208) |
| 2021 | $81,779 | 46 | Galderma Laboratories, L.P. ($76,618) |
| 2020 | $36,386 | 15 | MERZ NORTH AMERICA, INC. ($21,776) |
| 2019 | $95,110 | 130 | Merz North America, Inc. ($76,189) |
| 2018 | $98,036 | 89 | Merz North America, Inc. ($49,038) |
| 2017 | $48,979 | 63 | MERZ NORTH AMERICA, INC. ($20,379) |
All Payment Transactions
429 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| 11/14/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $3,480.00 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $2,475.00 | Research |
| Study: 43BBJ1911 | ||||||
| 10/24/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/01/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $10,440.00 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $20.08 | General |
| 09/13/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $2,162.40 | Research |
| Study: 43BBJ1911 | ||||||
| 08/16/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $6,378.00 | Research |
| Study: 43BBJ1911 | ||||||
| 07/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $130.00 | General |
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/12/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $1,368.80 | Research |
| Study: 43BBJ1911 | ||||||
| 06/21/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $6,844.00 | Research |
| Study: 43BBJ1911 | ||||||
| 06/20/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Food and Beverage | In-kind items and services | $20.30 | General |
| 05/30/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $147.97 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 04/05/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $2,737.60 | Research |
| Study: 43BBJ1911 | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $44.03 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $175.00 | General |
| 03/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $81.99 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $53.10 | General |
| 02/26/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $21.18 | General |
| 01/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $92.58 | General |
| 01/10/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $14.37 | General |
| 11/19/2023 | Merz North America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $395.04 | General |
| 11/19/2023 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $324.10 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| STUDY TO INVESTIGATE THE SAFETY AND DURATION OF EFFECT OF DIFFERENT BOTULINUM TOXIN A (NT 201) DOSE GROUPS FOLLOWING THE TREATMENT OF GLABELLAR FROWN LINES | Merz North America, Inc. | $59,743 | 4 |
| 43BBJ1911 | Galderma Laboratories, L.P. | $21,966 | 6 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of EN3835 In The Treatment Of Edematous Fibrosclerotic Panniculopathy Cellulite | Endo Pharmaceuticals Inc. | $1,787 | 11 |
| EVALUATION OF EFFECTIVENESS AND SAFETY OF RADIESSE (+) FOR THE IMPROVEMENT OF JAWLINE VOLUME AND CONTOUR | MERZ NORTH AMERICA, INC. | $1,089 | 8 |
About Dr. John Joseph, M.D
Dr. John Joseph, M.D is a Specialist healthcare provider based in Encino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487784047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Joseph, M.D has received a total of $458,108 in payments from pharmaceutical and medical device companies, with $36,903 received in 2024. These payments were reported across 429 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($152,883).
Ad
Practice Information
- Specialty Specialist
- Other Specialties Plastic Surgery Within the Head and Neck
- Location Encino, CA
- Active Since 03/06/2007
- Last Updated 02/10/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487784047
Products in Payments
- XEOMIN (Biological) $117,628
- BOTOX (Biological) $38,881
- Xeomin (Biological) $19,802
- XIAFLEX (Biological) $14,309
- BOTOX COSMETIC (Biological) $5,125
- DAXXIFY (Drug) $157.08
- SPIROX - LATERA (Device) $84.03
- KYBELLA (Biological) $32.57
- DYSPORT (Biological) $29.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Encino
Dr. David Kayne, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Douglas Sears, M.d, M.D
Specialist — Payments: $20,325
Specialist $20,325
Dr. Peyman Ghasri, M.d, M.D
Specialist — Payments: $16,849
Specialist $16,849
Dr. Michael Hollander, M.d, M.D
Specialist — Payments: $3,057
Specialist $3,057
Helene Rosenzweig, M.d, M.D
Specialist — Payments: $2,388
Specialist $2,388
Arthur Kowell, M.d, M.D
Specialist — Payments: $2,297
Specialist $2,297